A
Antonino Carbone
Researcher at University of Bari
Publications - 517
Citations - 20723
Antonino Carbone is an academic researcher from University of Bari. The author has contributed to research in topics: Lymphoma & Medicine. The author has an hindex of 77, co-authored 474 publications receiving 19748 citations. Previous affiliations of Antonino Carbone include University of Turin & University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
ALK+ Lymphoma: Clinico-Pathological Findings and Outcome
Brunangelo Falini,Stefano Pileri,Pier Luigi Zinzani,Antonino Carbone,Vittorina Zagonel,Chris De Wolf-Peeters,Gregor Verhoef,Fabio Menestrina,Giuseppe Todeschini,Marco Paulli,Mario Lazzarino,Roberta Giardini,Antonella Aiello,Hans Dieter Foss,Iguacyra Araujo,Marco Fizzotti,Pier Giuseppe Pelicci,L. Flenghi,Massimo F. Martelli,Antonella Santucci +19 more
TL;DR: Multivariate analysis identified ALK expression and the International Prognostic Index as independent variables that were able to predict survival among T/null primary, systemic anaplastic large-cell lymphoma.
Journal ArticleDOI
A multicenter study of treatment of primary CNS lymphoma
A. J. M. Ferreri,Michele Reni,F. Pasini,A. Calderoni,Umberto Tirelli,A. Pivnik,Gian Marco Aondio,F. Ferrarese,Henry L. Gomez,Maurilio Ponzoni,B. Borisch,F. Berger,C. Chassagne,Paolo Iuzzolino,Antonino Carbone,Joachim Weis,Ennio Pedrinis,T. Motta,A. Jouvet,T. Barbui,F. Cavalli,J. Y. Blay +21 more
TL;DR: Age, performance status, lactate dehydrogenase serum level, CSF protein level, site of disease, and use of HD-MTX were all predictors of survival, and combined CHT-RT is superior to RT alone.
Journal ArticleDOI
HIV-associated lymphomas and gamma-herpesviruses
TL;DR: The current knowledge about HIV-associated lymphomas can be summarized in the following key points: lymphomas specifically occurring in patients with HIV infection are closely linked to other viral diseases; AIDS lymphomas fall in a spectrum of B-cell differentiation where those associated with EBV or KSHV commonly exhibit plasmablastic differentiation.
Journal ArticleDOI
EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues
Maria Paola Martelli,Gabriella Sozzi,Luis Hernández,Valentina Pettirossi,Alba Navarro,Davide Conte,Patrizia Gasparini,Federica Perrone,Piergiorgio Modena,Ugo Pastorino,Antonino Carbone,Alessandra Fabbri,Angelo Sidoni,Shigeo Nakamura,Marcello Gambacorta,Pedro L. Fernández,José Ramírez,John K.C. Chan,Walter F. Grigioni,Elias Campo,Stefano Pileri,Brunangelo Falini +21 more
TL;DR: The results show that the causal role and value of EML4-ALK as a therapeutic target remain to be defined and that the EML3-ALK transcript cannot be regarded as a specific diagnostic tool for NSCLC.
Journal ArticleDOI
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Viviana Galimberti,Bernard F. Cole,Giuseppe Viale,Giuseppe Viale,Paolo Veronesi,Paolo Veronesi,Elisa Vicini,Mattia Intra,Giovanni Mazzarol,Samuele Massarut,Janez Zgajnar,Mario Taffurelli,David Littlejohn,Michael Knauer,Carlo Tondini,Angelo Di Leo,Marco Colleoni,Meredith M. Regan,Alan S. Coates,Richard D. Gelber,Aron Goldhirsch,Frances M. Boyle,Guy Jerusalem,Rolf A. Stahel,Stefan Aebi,Michael D. Green,Per Karlsson,Ingrid Kössler,István Láng,Anita Hiltbrunner,Jürg Bernhard,Stamatina Fournarakou,Roswitha Kammler,Rudolf Maibach,Manuela Rabaglio,Karin Ribi,Heidi Roschitzki,Susanne Roux,Barbara Ruepp,Caitlin Mahoney,Karen N. Price,Lynette Blacher,Tara Scolese,Karolyn Scott,Sandra Lippert,Theresa Zielinski,Mauro G. Mastropasqua,Stefania Andrighetto,Patrizia Dell'Orto,Giuseppe Renne,Giancarlo Pruneri,Silvia Dellapasqua,Monica Iorfida,Giuseppe Cancello,Emilia Montagna,Anna Cardillo,Giulia Peruzzotti,R. Ghisini,Alberto Luini,Umberto Veronesi,Oreste Gentilini,Stefano Zurrida,Giuseppe Curigliano,Franco Nolè,Roberto Orecchia,Marisa Cristina Leonardi,Paola Baratella,Camelia Chifu,Manuela Sargenti,Diana Crivellari,Sandro Morassut,Mario Mileto,Erica Piccoli,Andreas Veronesi,Marisa Donatella Magri,Angelo Buonadonna,Ezio Candiani,Antonino Carbone,Tiziana Perin,Rachele Volpe,Mario Roncadin,Mauro Arcicasa,Francesco Coran,Manuela Lagrassa,Angelo Recalcati,Maria Emanuela Limonta,Paolo Tricomi,Privato Fenaroli,Elisabetta Candiago,Laura Cattaneo,Alberto Gianatti,Donatella Santini,Sylvie Maweja,Philippe Delvenne,Andrée Rorive,Joëlle Collignon,Jean-Remi Garbay,Marie-Christine Mathieu,Hanne Galatius,Jack Hoffmann,Peer Schousen,Charlotte Lanng,John Hoerby,Birgitte Bruun Rasmussen,Helle Holtveg,Maj-Lis Moeller Talman,Julio Abugattas,Jose Manuel Cotrina,Richard Dyer,Jurij Lindtner,Elga Majdic,Snjezana Frkovic-Grazio,Christian Oehlschlegel,Gerhard Ries,Michael Töpfer,Ute Lorenz,Otto Schiltknecht,Bruno Späti,Andreas Ehrsam,Monika Bamert,Martina Egli-Tupaj,Christoph Rageth,Elisabeth Saurenmann,Christoph Tausch,Rosmarie Caduff,Holger Moch,Zsuzsanna Varga,Dimitri Sarlos,Elena Kralidis,Rainer Grobholz,Olivia Pagani,Lucia Bronz,Michele Ghielmini,Luca Mazzucchelli,Tiziana Rusca,Thomas Gyr,Linda Leidi,Giorgio Caccia,Daniel Wyss,Martin F. Fey,Michael Müller,Andreas Günthert,Gilles Berclaz,Achim Fleischmann,Jean Francois Delaloye,Assia Treboux,Hans-Anton Lehr,Maryse Fiche,L Perey,Lucien Zaman,Wendy Jeanneret Sozzi,John F. Forbes,D. F. Lindsay,D.F. Preece,Jane Hill,P. Jeal,P. Smart,John J. Collins,Gregory Bruce Mann,Robert Millar,Craig Murphy,Malcolm Buchanan,Anand Murugasu,James French,Elisabeth Elder,Lynette Mann,David Moon,A. Michael Bilous,Nirmala Pathmanathan,Virginia Howard,Petere G. Gill,James Kollias,Melissa Bochner,Linda Madigan,Elisabeth Rippy,Robert Whitfield,Fereshte Farshidi,Katrina Moore,Mark Sywak,L. Tan,William Ross,Karen Briscoe,Allison Jones,Aashit Shah,Elgene Lim,Robert Macindoe,Andrew J. Spillane,S. Fiona Bonar,Hugh Carmalt,Richard West,Cindy Mak,Paul McKenzie,Richard Harman,Susanne Gerred,Eva Juhasz,Stephen Allpress,Julie Craik,Ian G. Campbell,Paul Chin,Lori Hayes,Frederick Mayall,M. Thorburn +201 more
TL;DR: The findings of the IBCSG 23-01 trial corroborate those obtained at 5 years and are consistent with those of the 10-year follow-up analysis of the Z0011 trial, and support the current practice of not doing an axillary dissection when the tumour burden in the sentinel nodes is minimal or moderate.